India  

Bharat Biotech inks pact to supply Covaxin to Brazil

IndiaTimes Tuesday, 12 January 2021 ()
Vaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous Covid-19 vaccine Covaxin in the Brazilian market. The Covaxin doses will be manufactured in India and exported to Brazil where they will be distributed by Precisa.
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: ‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist

‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist 04:36

Dr Samiran Panda, scientist, India Council of Medical Research (ICMR) said that Bharat Biotech’s Covaxin will also provide immunity against covid-19 mutants. Panda added that India has taken a smart vaccination approach. “Covaxin presents to the immune system a wide array of antigens,” said...

💡 newsR Knowledge: Other News Mentions

Brazil Brazil Largest country in South America

India to begin commercial vaccine exports with shipments to Brazil, Morocco

India's government has cleared commercial exports of Covid-19 vaccines, with the first consignments to be shipped to Brazil and Morocco on Friday, the Indian..
IndiaTimes

India allows commercial export of COVID vaccines from Friday; first stop Brazil, Morocco

Brazil and Morocco will be the first two countries that are getting the commercial contracted supplies of 20 lakh doses each, of COVID-19 vaccines.
DNA
Brazil begins COVID-19 vaccine drive in Amazon [Video]

Brazil begins COVID-19 vaccine drive in Amazon

Brazilian military flew medical personnel and 1,000 doses of a Chinese vaccine deep into the Amazon rainforest on Tuesday to start inoculating indigenous people against the coronavirus. Gloria Tso reports.

Credit: Reuters Studio    Duration: 01:51Published
Brazil's COVID-hit indigenous receive vaccine [Video]

Brazil's COVID-hit indigenous receive vaccine

Brazilian military flew medical personnel and 1,000 doses of a Chinese vaccine deep into the Amazon rainforest on Tuesday to start inoculating indigenous people against the coronavirus. Gloria Tso reports.

Credit: Reuters Studio    Duration: 01:51Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against..
IndiaTimes
Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.

Credit: ANI    Duration: 01:30Published

Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin

Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said. ​​Out of the..
IndiaTimes

COVID-19: Who shouldn't take Covaxin? Bharat Biotech releases factsheet as concerns grow

Bharat Biotech issued the factsheet just two days after the launch of vaccination drive in the country.
DNA

BBV152 BBV152 Vaccine against COVID-19

‘Covid vaccines safe; politics on issue is unfortunate’: Health Minister [Video]

‘Covid vaccines safe; politics on issue is unfortunate’: Health Minister

Union Health minister Dr. Harsh Vardhan reiterated the two vaccines which have been granted approval for use in India are safe and effective. He added that some people are playing politics over the issue resulting in vaccine hesitancy among a section of the people. Harsh Vardhan said that the vaccines will be the last nail in the coffin of Covid. He also said that mild fever, pain and swelling are common after vaccination and added that very few people have shown these side-effects too. Questions have been raised about the safety of Covaxin which has not yet published any data from phase three clinical trials. Additionally, the government has also said that people will not get to choose a vaccine in the first phase. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 03:11Published
Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry [Video]

Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry

Health and Family Welfare Ministry of India on January 19 said that in case of the Covaxin which has been given emergency use authorization under clinical trial mode (Covaxin), hospitalization cost would be borne by authorities. He said, "There are two vaccines. One of the two vaccines is given emergency use authorization under clinical trial mode. In a document for this vaccine, it's mentioned that if there's causal relation between immunization and adverse event weather it is severe or serious, hospitalization cost would be borne by authorities."

Credit: ANI    Duration: 01:30Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Concerns grow that COVID vaccine misinformation campaigns are targeting Muslims [Video]

Concerns grow that COVID vaccine misinformation campaigns are targeting Muslims

With vaccination programmes being rolled out across the continent, health authorities are keen to see them adopted by all communities. But against them are anti-vaxx campaigns.

Credit: euronews (in English)    Duration: 01:36Published
Dr. Fauci vows to be 'completely transparent' on Covid-19 [Video]

Dr. Fauci vows to be 'completely transparent' on Covid-19

During a White House press briefing, Dr. Anthony Fauci told reporters that he feels liberated to speak freely and honestly about the coronavirus pandemic and the science behind it under the Biden administration.

Credit: Bleacher Report AOL    Duration: 02:28Published
Biden unveils Covid-19 plan on first full day in office [Video]

Biden unveils Covid-19 plan on first full day in office

President Joe Biden focuses on the Covid-19 pandemic in his first full day in office. CNN’s Phil Mattingly reports.

Credit: Bleacher Report AOL    Duration: 03:02Published
President Joe Biden signs executive orders to reshape fight against Covid-19 [Video]

President Joe Biden signs executive orders to reshape fight against Covid-19

President Joe Biden signs executive orders that will reshape the US's fightagainst Covid-19.

Credit: PA - Press Association STUDIO    Duration: 00:57Published

You Might Like


Related videos from verified sources

Covaxin: Do not inject if you have these conditions | Oneindia News [Video]

Covaxin: Do not inject if you have these conditions | Oneindia News

Covaxin maker Bharat Biotech has issued a fact sheet which details which categories of people should not be administered with the vaccine or which groups should take the vaccine with caution. Watch the..

Credit: Oneindia     Duration: 01:08Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made..

Credit: HT Digital Content     Duration: 08:15Published
Bharat Biotech's consent form for Covaxin recipients says...| Oneindia News [Video]

Bharat Biotech's consent form for Covaxin recipients says...| Oneindia News

Bharat Biotech has said that it will pay recipients of the vaccine Covaxin compensation if beneficiaries face any adverse effects after taking it while the vaccine remains in clinical trial mode. Watch..

Credit: Oneindia     Duration: 01:05Published

Related news from verified sources

Data | Covishield and Covaxin currently among the cheapest COVID-19 vaccines globally

Cost of inoculation campaign could eat up significant share of health budget
Hindu Also reported by •IndiaTimes

Bharat Biotech inks pact to supply Covaxin to Brazil

Vaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous...
IndiaTimes Also reported by •DNAHindu

Compensation if Covaxin causes serious adverse effect

Beneficiaries who receive Covaxin, a Bharat Biotech product, will be paid a compensation if they suffer a serious adverse event that is proven to be causally...
IndiaTimes